Investors oppose Korean poison pill amendment


In the letter sent to the Korean Ministry of Justice on Monday, 22 institutional investors with over USD2.5trillion in assets under management show their opposition to an amendment to Korean company law that would allow companies to introduce poison pills. The letter was sent out by F&C, a member of the Asian Corporate Governance Association (ACGA), who initiated this effort. «As a matter of principle, we tipically oppose poison pills because they are ofter used to shield management and protect the interests of related parties at the expense of public minority shareholders and wider economic efficiency and competitiveness», says the letter.